It is possible that the patient may develop the risk of hypophosphatemic rickets at a later stage, as many GACI patients with biallelic pathogenic variants in the ENPP1 gene progress to develop ARHR2 [22, 51]. Here, ENPP1 is linked to hypophosphatemic rickets.